| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9712 |
| Human Intestinal Absorption | HIA+ | 0.9829 |
| Caco-2 Permeability | Caco2+ | 0.7053 |
| P-glycoprotein Substrate | Substrate | 0.9173 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7031 |
| Non-inhibitor | 0.8397 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6108 |
| Distribution |
| Subcellular localization | Lysosome | 0.4752 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8678 |
| CYP450 2D6 Substrate | Substrate | 0.7836 |
| CYP450 3A4 Substrate | Substrate | 0.8022 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9409 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8912 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6514 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8578 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8133 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9418 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8552 |
| Non-inhibitor | 0.6577 |
| AMES Toxicity | Non AMES toxic | 0.7704 |
| Carcinogens | Non-carcinogens | 0.9335 |
| Fish Toxicity | High FHMT | 0.8688 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9927 |
| Honey Bee Toxicity | Low HBT | 0.5000 |
| Biodegradation | Not ready biodegradable | 0.9958 |
| Acute Oral Toxicity | II | 0.4542 |
| Carcinogenicity (Three-class) | Non-required | 0.6273 |